AP

Akash Paladia

Director Director DIN 09084021
DIN 09084021 First appointment Feb 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2021
Shareholding value Locked Premium profile

About Akash Paladia

Data last updated:

Akash Paladia has 5 years in corporate governance. Formerly with 1 company, such as Invitro Biomedicals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09084021
Primary Designation Director
First Appointment 27 Feb 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Invitro Biomedicals Private Limited U33119RJ2020PTC072553
Director27 Feb 20212020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Invitro Biomedicals Private Limited
Premium access

Shareholding and investment profile for Akash Paladia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Paladia

Akash Paladia has 5 years in corporate governance. Formerly with 1 company, such as Invitro Biomedicals Private Limited. Engaged in General Business. Contributes to corporate operations.

Akash Paladia is associated with 0 companies as a director.

Akash Paladia has expertise in General Business.

Akash Paladia has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available